findmyKOL

Mageda Mikhail, MD

Basic profile

Winthrop-University Hospital

ORCIDNone on fileNPI
RegionMineola, NY · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Mageda Mikhail is an Endocrinology/Metabolic physician affiliated with Winthrop-University Hospital. OpenAlex indexes 33 publications with 1,793 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
33publications

Distinct works indexed by OpenAlex.

1,793citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    53.7%
    Biguanide (metformin)18.1%
    Metformin Hcl52%Metformin Hcl Er48%
    Part D47 patients
    Insulin Analog12.6%
    Lantus Solostar28%Novolog Flexpen19%Basaglar Kwikpen U-10014%Tresiba Flextouch U-10013%Humalog Kwikpen U-10012%Tresiba Flextouch U-2007%Humalog7%
    Part D<11 patients

    + 5 more classes in this area

  • Hormonal (systemic)

    23.3%
    l-Thyroxine21.3%
    Levothyroxine Sodium56%Synthroid44%
    Part D54 patients
    Thyroid Hormone Synthesis Inhibitor2%
    Methimazole100%
    Part D<11 patients
  • Cardiovascular

    13.8%
    Statin9.1%
    Rosuvastatin Calcium47%Atorvastatin Calcium34%Simvastatin19%
    Part D<11 patients
    ACE inhibitor2.8%
    Enalapril Maleate64%Ramipril36%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”